X0306 4 2020-04-28 false 0001597553 Sage Therapeutics, Inc. SAGE 0001042021 JONAS JEFFREY M C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true true false false President & CEO Stock Option (Right to Buy) 39.87 2020-04-28 4 A false 15385.00 0.00 A 2030-04-28 Common Stock 15385.00 15385.00 D The securities awarded on April 28, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. 25% of the shares of common stock underlying this stock option award will vest on April 28, 2021, and the remaining 75% of the shares of common stock underlying this stock option award will vest on April 28, 2022, so long as the Reporting Person remains an employee or consultant of the Company on each of the applicable vesting dates. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Jeffrey M. Jonas 2020-04-30